|
Eine Ebene nach oben |
Gruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 7
Zeitschriftenartikel
Henes, Joerg C.; Saur, Sebastian; Kofler, David M.; Kedor, Claudia; Meisner, Christoph; Schuett, Marion; Krusche, Martin; Koetter, Ina; Xenitidis, Theodoros; Schulze-Koops, Hendrik und Feist, Eugen
(2022):
Tocilizumab for the Treatment of Familial Mediterranean Fever-A Randomized, Double-Blind, Placebo-Controlled Phase II Study.
In: Journal of Clinical Medicine, Bd. 11, Nr. 18, 5360
Preuße, Corinna; Paesler, Barbara; Nelke, Christopher; Cengiz, Derya; Müntefering, Thomas; Roos, Andreas; Amelin, Damien; Allenbach, Yves; Uruha, Akinori; Dittmayer, Carsten; Hentschel, Andreas; Pawlitzki, Marc; Hoffmann, Sarah; Timm, Sara; Louis, Sarah Leonard; Dengler, Nora F.; Wiendl, Heinz; Lunemann, Jan D.; Sickmann, Albert; Hervier, Baptiste; Meuth, Sven G.; Schneider, Udo; Schänzer, Anne; Krause, Sabine; Tomaras, Stylianos; Feist, Eugen; Hasseli, Rebecca; Goebel, Hans-Hilmar; Gallay, Laure; Streichenberger, Nathalie; Benveniste, Olivier; Stenzel, Werner und Ruck, Tobias
(2022):
Skeletal muscle provides the immunological micro-milieu for specific plasma cells in anti-synthetase syndrome-associated myositis.
In: Acta Neuropathologica, Bd. 144, Nr. 2: S. 353-372
Kedor, Claudia; Listing, Joachim; Zernicke, Jan; Weiss, Anja; Behrens, Frank; Blank, Norbert; Henes, Jörg Christoph; Kekow, Joern; Rubbert-Roth, Andrea; Schulze-Koops, Hendrik; Seipelt, Eva; Specker, Christof und Feist, Eugen
(2020):
Canakinumab for Treatment of Adult-Onset Still's Disease to Achieve Reduction of Arthritic Manifestation (CONSIDER): phase II, randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial.
In: Annals of the Rheumatic Diseases, Bd. 79, Nr. 8: S. 1090-1097
[PDF, 964kB]
Gabay, Cem; Fautrel, Bruno; Rech, Jürgen; Spertini, Francois; Feist, Eugen; Kötter, Ina; Hachulla, Eric; Morel, Jacques; Schaeverbeke, Thierry; Hamidou, Mohamed A.; Martin, Thierry; Hellmich, Bernhard; Lamprecht, Peter; Schulze-Koops, Hendrik; Courvoisier, Delphine Sophie; Sleight, Andrew und Schiffrin, Eduardo Jörge
(2018):
Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still's disease.
In: Annals of the Rheumatic Diseases, Bd. 77, Nr. 6: S. 840-847
[PDF, 744kB]
Bhattarai, Salyan; Ghannam, Khetam; Krause, Sabine; Benveniste, Olivier; Marg, Andreas; Bruin, Gerjan de; Xin, Bo-Tao; Overkleeft, Hermen S.; Spuler, Simone; Stenzel, Werner und Feist, Eugen
(2016):
The immunoproteasomes are key to regulate myokines and MHC class I expression in idiopathic inflammatory myopathies.
In: Journal of Autoimmunity, Bd. 75: S. 118-129
Nirmala, Nanguneri; Brachat, Arndt; Feist, Eugen; Blank, Norbert; Specker, Christof; Witt, Matthias; Zernicke, Jan; Martini, Alberto und Junge, Guido
(2015):
Gene-expression analysis of adult-onset Still's disease and systemic juvenile idiopathic arthritis is consistent with a continuum of a single disease entity.
In: Pediatric Rheumatology
13:50
[PDF, 7MB]
Ghannam, Khetam; Martinez-Gamboa, Lorena; Spengler, Lydia; Krause, Sabine; Smiljanovic, Biljana; Bonin, Marc; Bhattarai, Salyan; Grützkau, Andreas; Burmester, Gerd-R.; Häupl, Thomas und Feist, Eugen
(2014):
Upregulation of Immunoproteasome Subunits in Myositis Indicates Active Inflammation with Involvement of Antigen Presenting Cells, CD8 T-Cells and IFN gamma.
In: PLOS ONE 9(8), e104048 [PDF, 4MB]
In: PLOS ONE 9(8), e104048 [PDF, 4MB]